Bank of Montreal’s Acer Therapeutics Inc ACER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,331
Closed -$5K 4984
2020
Q2
$5K Sell
1,331
-2,902
-69% -$8.19K ﹤0.01% 4432
2020
Q1
$7K Sell
4,233
-9,637
-69% -$35.3K ﹤0.01% 3614
2019
Q4
$56K Sell
13,870
-9,271
-40% -$31.5K ﹤0.01% 3794
2019
Q3
$74K Buy
23,141
+17,722
+327% +$52K ﹤0.01% 3446
2019
Q2
$22K Buy
5,419
+2,209
+69% +$42.1K ﹤0.01% 4134
2019
Q1
$78K Hold
3,210
﹤0.01% 3173
2018
Q4
$64K Buy
3,210
+1,605
+100% +$37K ﹤0.01% 3182
2018
Q3
$49K Buy
+1,605
New +$43K ﹤0.01% 3402

Other funds holding ACER

Bank of Montreal's ACER Position: Q3 2020 in Review

Bank of Montreal sold out of Acer Therapeutics Inc (ACER) in Q3 2020, closing a stake of 1,331 shares — an estimated $5K sold.

Bank of Montreal first reported a position in ACER in Q3 2018 and held it in 8 quarters. The position peaked at $78K in Q1 2019. 27 funds tracked by Wall St. Rank hold ACER as of Q3 2020.

  • Bank of Montreal reported no remaining Acer Therapeutics Inc position as of Q3 2020 after selling out during the quarter.
  • Bank of Montreal sold 1,331 Acer Therapeutics Inc shares in Q3 2020, an estimated $5K.
  • Bank of Montreal first reported a position in Acer Therapeutics Inc in Q3 2018 and held it in 8 quarters.
  • Bank of Montreal's Acer Therapeutics Inc position peaked at $78K in Q1 2019.
  • 27 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q3 2020.

Based on Bank of Montreal's 13F filing for Q3 2020, filed 12 Nov 2020.